AlphaCrest Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,745
Closed -$1.2M 692
2022
Q3
$1.2M Buy
19,745
+3,060
+18% +$195K 0.07% 494
2022
Q2
$1.05M Buy
16,685
+6,513
+64% +$431K 0.05% 639
2022
Q1
$715K Sell
10,172
-39,398
-79% -$2.66M 0.04% 716
2021
Q4
$3.1M Buy
49,570
+15,679
+46% +$984K 0.12% 215
2021
Q3
$2.09M Sell
33,891
-123,486
-78% -$7.43M 0.11% 286
2021
Q2
$9.42M Buy
157,377
+73,163
+87% +$4.64M 0.4% 19
2021
Q1
$5.12M Sell
84,214
-97,976
-54% -$5.41M 0.29% 64
2020
Q4
$8.55M Buy
182,190
+105,247
+137% +$4.56M 0.71% 7
2020
Q3
$2.86M Sell
76,943
-4,948
-6% -$188K 0.31% 46
2020
Q2
$2.99M Buy
81,891
+58,975
+257% +$2.05M 0.5% 19
2020
Q1
$701K Sell
22,916
-9,594
-30% -$425K 0.09% 421
2019
Q4
$1.66M Sell
32,510
-113,825
-78% -$5.49M 0.14% 161
2019
Q3
$6.9M Buy
146,335
+111,625
+322% +$5.32M 0.42% 12
2019
Q2
$1.72M Sell
34,710
-6,497
-16% -$305K 0.15% 192
2019
Q1
$1.75M Buy
+41,207
New +$1.82M 0.27% 62

Other funds holding MET

AlphaCrest Capital Management's MET Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of MetLife (MET) in Q4 2022, closing a stake of 19,745 shares — an estimated $1.2M sold.

AlphaCrest Capital Management first reported a position in MET in Q1 2019 and held it in 15 quarters. The position peaked at $9.42M in Q2 2021. 1,314 funds tracked by Wall St. Rank hold MET as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining MetLife position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 19,745 MetLife shares in Q4 2022, an estimated $1.2M.
  • AlphaCrest Capital Management first reported a position in MetLife in Q1 2019 and held it in 15 quarters.
  • AlphaCrest Capital Management's MetLife position peaked at $9.42M in Q2 2021.
  • 1,314 funds tracked by Wall St. Rank held MetLife as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.